This inventor holds 3 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung E.v.. Active years: 2018-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2023
Title: Inventor Spotlight: Andreas Von Knethen from Nidderau, Germany
Introduction
Andreas Von Knethen is a notable inventor based in Nidderau, Germany, known for his contributions to the field of medical innovations, particularly in treatments aimed at preventing organ failure. With a total of three patents to his name, his work showcases a strong commitment to developing effective therapeutic agents.
Latest Patents
Among Andreas's latest inventions are his patents involving B7-H1 fusion polypeptides, specifically designed for treating and preventing organ failure in subjects suffering from sepsis. The fusion polypeptide comprises two crucial components: a Fc portion of an immunoglobulin and the extracellular portion of the human B7-H1 polypeptide or a variant thereof. Additionally, the invention includes a polynucleotide encoding this fusion polypeptide, highlighting its potential for therapeutic applications in critically ill patients.
Career Highlights
Andreas has made significant strides in the biomedical field while working with the Fraunhofer Society for the Advancement of Applied Research, a leading research organization in Germany. His expertise and innovative spirit have enabled him to pursue groundbreaking solutions in medicine.
Collaborations
Throughout his career, Andreas has collaborated with esteemed colleagues such as Michael John Parnham and Lisa Katharina Sha. These partnerships have enhanced the development of his patented technologies and contributed to the advancement of biomedical research.
Conclusion
In summary, Andreas Von Knethen is an influential inventor whose work in creating therapeutic peptides for organ failure prevention exemplifies the potential of biomedical innovations. His expertise, combined with strategic collaborations, places him at the forefront of vital research aimed at improving patient outcomes. With his continued dedication to innovation, Andreas is poised to make even more significant contributions in the future.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile